PERIOPERATIVE DURVALUMAB IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCER.(02-09-2025)

ENCORAFENIB, CETUXIMAB, AND mFOLFOX6 IN BRAF-MUTATED COLONRECTAL CANCER.(15-07-2025)

FRUQUINTINIB VERSUS PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLONRECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY.(08-07-2025)

ZOLBETUXIMAB PLUS mFOLFOX6 IN PATIENTS WITH CLDN18.2-positive, HER2-negative, UNTREATED, LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC OR GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA (SPOTLIGHT): A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE III  TRIAL.(24-06-2025)

FRUQUINTINIB versus PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY.(01-04-2025)

RIPRETINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOURS (INVICTUS): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 3 TRIAL.(21-01-2025)

NEOADJUVANT CHEMOTHERAPY WITH OXALIPLATIN AND FLUOROPYRIMIDINE VERSUS UPFRONT SURGERY FOR LOCALLY ADVANCED COLON CANCER: THE RANDOMIZED, PHASE III OPTICAL TRIAL. (05-11-2024)

NEOADJUVANT DOCETAXEL, OXALIPLATIN, AND S-1 SURGERY AND ADJUVANT S-1 FOR RESECTABLE ADVANCED GASTRIC CANCER: UPDATED OVERALL SURVIVAL OUTCOMES FROM PHASE III PRODIGY. (29-10-2024)

OXALIPLATIN-BASED ADJUVANT CHEMOTHERAPY IN OLDER PATIENTS WITH STAGE III COLON CANCER: AN ACCENT/IDEA POOLED ANALYSIS OF 12 TRIALS. (03 Settembre 2024)

IMPROVED CLINICAL STAGING SYSTEM FOR LOCALIZED PANCREATIC CANCER USING THE ABC FACTORS: A TAPS CONSORTIUM STUDY. (18 Giugno 2024)

TRASTUZUMAB PLUS GEMCITABINE-CISPLATIN FOR TREATMENT-NAIVE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE BILIARY TRACT ADENOCARCINOMA: A MULTICENTER, OPEN-LABEL, PHASE II STUDY (TAB). (11 Giugno 2024)

FRUQUINTINIB VERSUS PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY. (26 Marzo 2024)

NANOLIPOSOMAIL IRINOTECAN WITH FLUOROURACIL AND FOLINIC ACID IN METASTATIC PANCREATIC CANCER AFTER PREVIOUS GEMCITABINE-BASED THERAPY (NAPOLI-1): A GLOBAL, RANDOMISED, OPEN-LABEL, PHASE 3 TRIAL. (26 Marzo 2024)

EFFECT OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY ON CYTOREDUCTIVE SURGERY IN GASTRIC CANCER WITH SYNCHRONOUS PERITONEAL METASTASES: THE PHASE III GASTRIPEC-I TRIAL. (12 Marzo 2024)